Title
Caveolin-1 regulates the anti-atherogenic properties of macrophages
Date Issued
16 November 2014
Access level
metadata only access
Resource Type
journal article
Author(s)
Pavlides S.
Katiyar S.
Jasmin J.F.
Mercier I.
Walters R.
Pavlides C.
Pestell R.G.
Lisanti M.P.
Frank P.G.
University, Philadelphia
Publisher(s)
Springer Verlag
Abstract
Atherosclerosis is a complex disease initiated by the vascular accumulation of lipoproteins in the sub-endothelial space, followed by the infiltration of monocytes into the arterial intima. Caveolin-1 (Cav-1) plays an essential role in the regulation of cellular cholesterol metabolism and of various signaling pathways. In order to study specifically the role of macrophage Cav-1 in atherosclerosis, we used Cav-1−/−Apoe−/− mice and transplanted them with bone marrow (BM) cells obtained from Cav-1+/+Apoe−/− or Cav-1−/−Apoe−/− mice and vice versa. We found that Cav-1+/+ mice harboring Cav-1−/− BM-derived macrophages developed significantly larger lesions than Cav-1+/+ mice harboring Cav-1+/+ BM-derived macrophages. Cav-1−/− macrophages were more susceptible to apoptosis and more prone to induce inflammation. The present study provides clear evidence that the absence of Cav-1 in macrophage is pro-atherogenic, whereas its absence in endothelial cells protects against atherosclerotic lesion formation. These findings demonstrate the cell-specific role of Cav-1 during the development of this disease.
Start page
821
End page
831
Volume
358
Issue
3
Language
English
OCDE Knowledge area
Nutrición, Dietética
Subjects
Scopus EID
2-s2.0-84912119558
PubMed ID
Source
Cell and Tissue Research
ISSN of the container
0302-766X
Sponsor(s)
Acknowledgments The authors thank Dr. Iset Medina Vera for her technical support. P.G.F. was supported by grants from the Jane Barsumian/Mary Lyons Trust and the W.W. Smith Trust Fund. M.P.L. was supported by grants from the National Institutes of Health and the American Heart Association.
Sources of information:
Directorio de Producción Científica
Scopus